Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interaction of 8-anilinonaphthalene-1-sulfonate with SARS-CoV-2 main protease and its application as a fluorescent probe for inhibitor identification
Peerapon Deetanya, Kowit Hengphasatporn, Patcharin Wilasluck, et al.
Computational and Structural Biotechnology Journal (2021) Vol. 19, pp. 3364-3371
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

Halogenated Baicalein as a Promising Antiviral Agent toward SARS-CoV-2 Main Protease
Kowit Hengphasatporn, Patcharin Wilasluck, Peerapon Deetanya, et al.
Journal of Chemical Information and Modeling (2022) Vol. 62, Iss. 6, pp. 1498-1509
Closed Access | Times Cited: 55
Tenofovir antiviral drug solubility enhancement with β-cyclodextrin inclusion complex and in silico study of potential inhibitor against SARS-CoV-2 main protease (Mpro)
Sonaimuthu Mohandoss, Kuppu Sakthi Velu, Stalin Thambusamy, et al.
Journal of Molecular Liquids (2023) Vol. 377, pp. 121544-121544
Open Access | Times Cited: 21
FMO-guided design of darunavir analogs as HIV-1 protease inhibitors
Hathaichanok Chuntakaruk, Kowit Hengphasatporn, Yasuteru Shigeta, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 8
Targeting the receptor binding domain and heparan sulfate binding for antiviral drug development against SARS-CoV-2 variants
Zi-Sin Yang, Tzong-Shiun Li, Yu-Sung Huang, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 7
Promising SARS-CoV-2 main protease inhibitor ligand-binding modes evaluated using LB-PaCS-MD/FMO
Kowit Hengphasatporn, Ryuhei Harada, Patcharin Wilasluck, et al.
Scientific Reports (2022) Vol. 12, Iss. 1
Open Access | Times Cited: 30
Design, Synthesis, and Antiviral Activity of Fragmented-Lapatinib Aminoquinazoline Analogs towards SARS-CoV-2 Inhibition
Ayomide Olamide Adediji, Akeanan Sroithongmoon, Aphinya Suroengrit, et al.
European Journal of Medicinal Chemistry (2025), pp. 117303-117303
Closed Access
Unveiling the antiviral inhibitory activity of ebselen and ebsulfur derivatives on SARS-CoV-2 using machine learning-based QSAR, LB-PaCS-MD, and experimental assay
Silpsiri Sinsulpsiri, Yuji Nishii, Qing‐Feng Xu‐Xu, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access
Pharmacogenetics and Precision Medicine Approaches for the Improvement of COVID-19 Therapies
Mohitosh Biswas, Nares Sawajan, Thanyada Rungrotmongkol, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 22
Semi-Synthesis of N-Aryl Amide Analogs of Piperine from Piper nigrum and Evaluation of Their Antitrypanosomal, Antimalarial, and Anti-SARS-CoV-2 Main Protease Activities
Rattanaporn Wansri, Aye Chan Khine Lin, Jutharat Pengon, et al.
Molecules (2022) Vol. 27, Iss. 9, pp. 2841-2841
Open Access | Times Cited: 17
Identification of repurposing therapeutics toward SARS-CoV-2 main protease by virtual screening
Kamonpan Sanachai, Tuanjai Somboon, Patcharin Wilasluck, et al.
PLoS ONE (2022) Vol. 17, Iss. 6, pp. e0269563-e0269563
Open Access | Times Cited: 14
Galangal–Cinnamon Spice Mixture Blocks the Coronavirus Infection Pathway through Inhibition of SARS-CoV-2 MPro, Three HCoV-229E Targets; Quantum-Chemical Calculations Support In Vitro Evaluation
Doaa G. El-Hosari, Wesam M. Hussein, Marwa O. Elgendy, et al.
Pharmaceuticals (2023) Vol. 16, Iss. 10, pp. 1378-1378
Open Access | Times Cited: 8
Monitoring protein conformational changes using fluorescent nanoantennas
Scott G. Harroun, Dominic Lauzon, Maximilian C. C. J. C. Ebert, et al.
Nature Methods (2021) Vol. 19, Iss. 1, pp. 71-80
Open Access | Times Cited: 19
Special Features of COVID-19 in the FMODB: Fragment Molecular Orbital Calculations and Interaction Energy Analysis of SARS-CoV-2-Related Proteins
Kaori Fukuzawa, Koichiro Kato, Chiduru Watanabe, et al.
Journal of Chemical Information and Modeling (2021) Vol. 61, Iss. 9, pp. 4594-4612
Open Access | Times Cited: 18
SARS-CoV-2 main protease (3CLpro) interaction with acyclovir antiviral drug/methyl-β-cyclodextrin complex: Physiochemical characterization and molecular docking
Sonaimuthu Mohandoss, Ramaraj Sukanya, Sivarasan Ganesan, et al.
Journal of Molecular Liquids (2022) Vol. 366, pp. 120292-120292
Open Access | Times Cited: 13
Quantum Chemical Interaction Analysis between SARS-CoV-2 Main Protease and Ensitrelvir Compared with Its Initial Screening Hit
Chiduru Watanabe, Shigenori Tanaka, Yoshio Okiyama, et al.
The Journal of Physical Chemistry Letters (2023) Vol. 14, Iss. 15, pp. 3609-3620
Closed Access | Times Cited: 7
Food phytochemicals, epigallocatechin gallate and myricetin, covalently bind to the active site of the coronavirus main protease in vitro
Yoji Kato, Akari Higashiyama, Emi Takaoka, et al.
Advances in Redox Research (2021) Vol. 3, pp. 100021-100021
Open Access | Times Cited: 15
Discovery of C-12 dithiocarbamate andrographolide analogues as inhibitors of SARS-CoV-2 main protease: In vitro and in silico studies
Bodee Nutho, Patcharin Wilasluck, Peerapon Deetanya, et al.
Computational and Structural Biotechnology Journal (2022) Vol. 20, pp. 2784-2797
Open Access | Times Cited: 10
Identification of Promising Sulfonamide Chalcones as Inhibitors of SARS-CoV-2 3CLpro through Structure-Based Virtual Screening and Experimental Approaches
Piyatida Pojtanadithee, Kowit Hengphasatporn, Aphinya Suroengrit, et al.
Journal of Chemical Information and Modeling (2023) Vol. 63, Iss. 16, pp. 5244-5258
Closed Access | Times Cited: 5
Plant Molecular Pharming and Plant-Derived Compounds towards Generation of Vaccines and Therapeutics against Coronaviruses
Srividhya Venkataraman
Vaccines (2022) Vol. 10, Iss. 11, pp. 1805-1805
Open Access | Times Cited: 9
Designing Potent α-Glucosidase Inhibitors: A Synthesis and QSAR Modeling Approach for Biscoumarin Derivatives
Thi-Hong-Truc Phan, Kowit Hengphasatporn, Yasuteru Shigeta, et al.
ACS Omega (2023) Vol. 8, Iss. 29, pp. 26340-26350
Open Access | Times Cited: 4
Ligand Binding Path Sampling Based on Parallel Cascade Selection Molecular Dynamics: LB-PaCS-MD
Hayato Aida, Yasuteru Shigeta, Ryuhei Harada
Materials (2022) Vol. 15, Iss. 4, pp. 1490-1490
Open Access | Times Cited: 7
N-Containing α-Mangostin Analogs via Smiles Rearrangement as the Promising Cytotoxic, Antitrypanosomal, and SARS-CoV-2 Main Protease Inhibitory Agents
Nan Yadanar Lin Pyae, Arnatchai Maiuthed, Wongsakorn Phongsopitanun, et al.
Molecules (2023) Vol. 28, Iss. 3, pp. 1104-1104
Open Access | Times Cited: 3
A combination of structure-based virtual screening and experimental strategies to identify the potency of caffeic acid ester derivatives as SARS-CoV-2 3CLpro inhibitor from an in-house database
Piyatida Pojtanadithee, Kulpornsorn Isswanich, Koonchira Buaban, et al.
Biophysical Chemistry (2023) Vol. 304, pp. 107125-107125
Open Access | Times Cited: 3
Identification of possible SARS-CoV-2 main protease inhibitors: in silico molecular docking and dynamic simulation studies
Aniruddhya Mukherjee, Khushhali M. Pandey, Krishna Kumar Ojha, et al.
Beni-Suef University Journal of Basic and Applied Sciences (2023) Vol. 12, Iss. 1
Open Access | Times Cited: 2
In Silico and In Vitro Potential of FDA-Approved Drugs for Antimalarial Drug Repurposing against Plasmodium Serine Hydroxymethyltransferases
Pitchayathida Mee-udorn, Kochakorn Phiwkaow, Ruchanok Tinikul, et al.
ACS Omega (2023) Vol. 8, Iss. 39, pp. 35580-35591
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top